Cargando…

Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro

Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Mengxin, Deng, Yuan, Zhao, Zhimin, Yang, Depo, Wan, Guohui, Xu, Xinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052065/
https://www.ncbi.nlm.nih.gov/pubmed/36985397
http://dx.doi.org/10.3390/molecules28062426
_version_ 1785015059969212416
author Yao, Mengxin
Deng, Yuan
Zhao, Zhimin
Yang, Depo
Wan, Guohui
Xu, Xinjun
author_facet Yao, Mengxin
Deng, Yuan
Zhao, Zhimin
Yang, Depo
Wan, Guohui
Xu, Xinjun
author_sort Yao, Mengxin
collection PubMed
description Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel selenium nanoparticle (Se-MOP) was prepared to solve these problems using MOP as a dispersant. The zeta potential was measured to evaluate the stability, and UV and ATR-FTIR were used to investigate the binding type of selenium and MOP. The morphology was observed by the TEM method. Furthermore, the inhibitory effect on five selected cancer cells (HepG2, MCF-7, AGS, PC9, and HCT8) was evaluated, showing remarkable inhibition of all five cancer cells. The mechanism of inhibition was also investigated by cell circle assay, and it was found that Se-MOP could induce cell circle G0/G1 phase arrest. Immune-enhancing activities were evaluated by measuring the proliferation and cytokines of mouse spleen lymphocytes in vitro and quantitative RT-PCR. The results indicated that single stimulation of Se-MOP and synergistic stimulation with PHA or LPS increased immune capacity and improved immune by increasing the expression of cytokines.
format Online
Article
Text
id pubmed-10052065
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100520652023-03-30 Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro Yao, Mengxin Deng, Yuan Zhao, Zhimin Yang, Depo Wan, Guohui Xu, Xinjun Molecules Article Recently, selenium nanoparticles have been drawing attention worldwide, and it is crucial to increase the stability of nano-Se. Morinda officinalis polysaccharides (MOP) are the main active component in Morinda officinalis radix. However, their low activity has limited their application. A novel selenium nanoparticle (Se-MOP) was prepared to solve these problems using MOP as a dispersant. The zeta potential was measured to evaluate the stability, and UV and ATR-FTIR were used to investigate the binding type of selenium and MOP. The morphology was observed by the TEM method. Furthermore, the inhibitory effect on five selected cancer cells (HepG2, MCF-7, AGS, PC9, and HCT8) was evaluated, showing remarkable inhibition of all five cancer cells. The mechanism of inhibition was also investigated by cell circle assay, and it was found that Se-MOP could induce cell circle G0/G1 phase arrest. Immune-enhancing activities were evaluated by measuring the proliferation and cytokines of mouse spleen lymphocytes in vitro and quantitative RT-PCR. The results indicated that single stimulation of Se-MOP and synergistic stimulation with PHA or LPS increased immune capacity and improved immune by increasing the expression of cytokines. MDPI 2023-03-07 /pmc/articles/PMC10052065/ /pubmed/36985397 http://dx.doi.org/10.3390/molecules28062426 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yao, Mengxin
Deng, Yuan
Zhao, Zhimin
Yang, Depo
Wan, Guohui
Xu, Xinjun
Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title_full Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title_fullStr Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title_full_unstemmed Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title_short Selenium Nanoparticles Based on Morinda officinalis Polysaccharides: Characterization, Anti-Cancer Activities, and Immune-Enhancing Activities Evaluation In Vitro
title_sort selenium nanoparticles based on morinda officinalis polysaccharides: characterization, anti-cancer activities, and immune-enhancing activities evaluation in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052065/
https://www.ncbi.nlm.nih.gov/pubmed/36985397
http://dx.doi.org/10.3390/molecules28062426
work_keys_str_mv AT yaomengxin seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro
AT dengyuan seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro
AT zhaozhimin seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro
AT yangdepo seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro
AT wanguohui seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro
AT xuxinjun seleniumnanoparticlesbasedonmorindaofficinalispolysaccharidescharacterizationanticanceractivitiesandimmuneenhancingactivitiesevaluationinvitro